Herbert Kuster
Herbert Kuster
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich
Verified email at usz.ch
Title
Cited by
Cited by
Year
Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
A Trkola, H Kuster, P Rusert, B Joos, M Fischer, C Leemann, A Manrique, ...
Nature medicine 11 (6), 615-622, 2005
5842005
HIV rebounds from latently infected cells, rather than from continuing low-level replication
B Joos, M Fischer, H Kuster, SK Pillai, JK Wong, J Böni, B Hirschel, ...
Proceedings of the National Academy of Sciences 105 (43), 16725-16730, 2008
2922008
Covalent attachment of hybridizable oligonucleotides to glass supports
B Joos, H Kuster, R Cone
Analytical biochemistry 247 (1), 96-101, 1997
2231997
Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection
R Weber, P Deplazes, M Flepp, A Mathis, R Baumann, B Sauer, H Kuster, ...
New England Journal of Medicine 336 (7), 474-478, 1997
1391997
Two Encephalitozoon cuniculi strains of human origin are infectious to rabbits
A Mathis, M Michel, H Kuster, C Müller, R Weber, P Deplazes
Parasitology 114 (1), 29-35, 1997
1161997
Disseminated Microsporidiosis Due to Encephalitozoon hellem: Pulmonary Colonization, Microhematuria, and Mild Conjunctivitis in a Patient with AIDS
R Weber, H Kuster, GS Visvesvara, RT Bryan, DA Schwartz, R Lüthy
Clinical Infectious Diseases 17 (3), 415-419, 1993
1111993
Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection
M Huber, M Fischer, B Misselwitz, A Manrique, H Kuster, B Niederöst, ...
PLoS Med 3 (11), e441, 2006
1092006
Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients
S Gianella, L Haeberli, B Joos, B Ledergerber, RP Wüthrich, R Weber, ...
Transplant infectious disease 12 (1), 1-10, 2010
1022010
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10
A Manrique, P Rusert, B Joos, M Fischer, H Kuster, C Leemann, ...
Journal of virology 81 (16), 8793-8808, 2007
1012007
Virus isolates during acute and chronic human immunodeficiency virus type 1 infection show distinct patterns of sensitivity to entry inhibitors
P Rusert, H Kuster, B Joos, B Misselwitz, C Gujer, C Leemann, M Fischer, ...
Journal of virology 79 (13), 8454-8469, 2005
982005
Pulmonary and intestinal microsporidiosis in a patient with the acquired immunodeficiency syndrome
R Weber, H Kuster, R Keller, T Bächi, MA Spycher, J Briner, E Russi, ...
American Review of Respiratory Disease 146, 1603-1603, 1992
971992
Quantification of infectious HIV-1 plasma viral load using a boosted in vitro infection protocol
P Rusert, M Fischer, B Joos, C Leemann, H Kuster, M Flepp, S Bonhoeffer, ...
Virology 326 (1), 113-129, 2004
962004
Characterization of human immunodeficiency virus type 1 (HIV-1) diversity and tropism in 145 patients with primary HIV-1 infection
P Rieder, B Joos, AU Scherrer, H Kuster, D Braun, C Grube, B Niederöst, ...
Clinical infectious diseases 53 (12), 1271-1279, 2011
912011
Determinants of HIV-1 broadly neutralizing antibody induction
P Rusert, RD Kouyos, C Kadelka, H Ebner, M Schanz, M Huber, DL Braun, ...
Nature medicine 22 (11), 1260-1267, 2016
902016
Long-term multiple-dose pharmacokinetics of human monoclonal antibodies (MAbs) against human immunodeficiency virus type 1 envelope gp120 (MAb 2G12) and gp41 (MAbs 4E10 and 2F5)
B Joos, A Trkola, H Kuster, L Aceto, M Fischer, G Stiegler, C Armbruster, ...
Antimicrobial Agents and Chemotherapy 50 (5), 1773-1779, 2006
832006
HIV-1 transmission after cessation of early antiretroviral therapy among men having sex with men
P Rieder, B Joos, V von Wyl, H Kuster, C Grube, C Leemann, J Böni, ...
Aids 24 (8), 1177-1183, 2010
762010
Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae
MG Täuber, M Burroughs, UM Niemö11er, H Kuster, U Borschberg, ...
Journal of infectious diseases 163 (4), 806-811, 1991
731991
A method for the quantification of intracellular zidovudine nucleotides
H Kuster, M Vogt, B Joos, V Nadai, R Lüthy
Journal of Infectious Diseases 164 (4), 773-776, 1991
591991
In vivo efficacy of human immunodeficiency virus neutralizing antibodies: estimates for protective titers
A Trkola, H Kuster, P Rusert, V von Wyl, C Leemann, R Weber, G Stiegler, ...
Journal of virology 82 (3), 1591-1599, 2008
582008
Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing …
KJ Metzner, P Rauch, V von Wyl, C Leemann, C Grube, H Kuster, J Böni, ...
The Journal of infectious diseases 201 (7), 1063-1071, 2010
572010
The system can't perform the operation now. Try again later.
Articles 1–20